Abstract The coronavirus disease 2019 (COVID-19) was declared a pandemic in March
2020 by the World Health Organization (WHO). To date, there were> 163 million confirmed …

The COVID-19 pandemic examines not only the state of actual health care but also the state
of fundamental medicine in various countries. Pro-inflammatory processes extend far …

Hyper-inflammation associated with cytokine storm syndrome causes high mortality in
patients with COVID-19. Glucocorticoids, such as methylprednisolone sodium succinate …

Emetine is a FDA-approved drug for the treatment of amebiasis. Previously we
demonstrated the antiviral efficacy of emetine against some RNA and DNA viruses. In this …

Abstract The coronavirus disease 2019 (COVID-19) caused by coronavirus SARS-CoV-2
infection has become a global pandemic due to the high viral transmissibility and …

Severe COVID-19 patients present a clinical and laboratory overlap with other
hyperinflammatory conditions such as hemophagocytic lymphohistiocytosis (HLH) …

Exhaustion of immune cells in COVID-19 remains a serious concern for infection
management and therapeutic interventions. As reported, immune cells such as T effector …

COVID-19, caused by the SARS-CoV-2 virus, is a respiratory infectious disease. While most
patients recover after treatment, there is growing evidence that COVID-19 may result in …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is identified as the cause of
coronavirus disease 2019 (COVID-19), and is often linked to extreme inflammatory …

Background Human immunodeficiency virus infection (HIV) is a presumed risk factor for
severe coronavirus disease 2019 (COVID-19), yet little is known about COVID-19 outcomes …